- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Is Omicron Variant Nature's Immunization Against Delta Variant?
The B.1.1.529 variant was first reported to WHO from South Africa on November 24, 2021. The Omicron variant diverges from the original SARS-CoV-2 virus by about 50 mutations, including more than two dozen in the spike protein. Omicron infections are rapidly expanding worldwide often in the face of high levels of Delta infections. Early findings of the recent South African study suggests infection with the SARS-CoV-2 Omicron variant creates a neutralising immune response against the Delta variant. The study findings has been submitted as a preprint to medRxiv on December 27, 2021.
Omicron has been shown to be highly transmissible and have extensive evasion of neutralising antibody immunity elicited by vaccination and previous SARS-CoV-2 infection. Studies carried out in South Africa and the United Kingdom show that people infected with Omicron tend to have milder illnesses compared to Delta.
While Omicron infections are rising steeply, many countries still have high levels of infection with the Delta variant. Also, the data on the interaction between Delta and Omicron remains unclear. Therefore, Dr Alex Sigal and his team characterized developing immunity to Omicron and investigated whether neutralising immunity elicited by Omicron also enhances neutralising immunity of the Delta variant.
They enrolled a total of 15 previously vaccinated and unvaccinated people who were infected with the Omicron variant. All had been admitted to the hospital but only four required supplemental oxygen. They used plasma containing antibodies, from the participants to test the ability of the antibodies to control both Omicron and Delta in the lab – a so-called 'neutralisation' test. They used a live virus neutralisation assay to measure participants' ability to neutralize Omicron and Delta during the onset of symptoms and again around two weeks later.
Key findings of the study:
- Upon analysis, the researchers found that neutralisation of Omicron increased 14-fold over this time, showing a developing antibody response to the variant.
- They also found an enhancement of Delta virus neutralisation which increased 4.4-fold.
The authors concluded, "The increase in Delta variant neutralisation in individuals infected with Omicron may result in a decreased ability of Delta to re-infect those individuals."
They further added, "Along with emerging data indicating that Omicron, at this time in the pandemic, is less pathogenic than Delta, such an outcome may have positive implications in terms of decreasing the Covid-19 burden of severe disease."
However, they cautioned that participants in this study were likely to have been previously infected. In addition, more than half were vaccinated. Thus, they warned it's "unclear if what we observe is effective cross-neutralisation of Delta virus by Omicron elicited antibodies or activation of antibody immunity from previous infection and/or vaccination."
For further information:
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751